GB Patent

GB0401876D0 — New use for cancer antigen

Assigned to Topotarget UK Ltd · Expires 2004-03-03 · 22y expired

What this patent protects

Patent listed against Beleodaq.

Drugs covered by this patent

Beleodaq (belinostat) · Acrotech Biopharma

Patent Metadata

Patent number: GB0401876D0
Jurisdiction: GB
Classification: —
Expires: 2004-03-03
Drug substance claim: No
Drug product claim: No
Assignee: Topotarget UK Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.